Cowen Remains Bullish on United Therapeutics (UTHR) as Orenitram Continues to Grow

October 27, 2015 4:01 PM

Cowen reiterated an Outperform rating and $185.00 price target on United Therapeutics Corp. (NASDAQ: UTHR) following the company's 3Q15 earnings ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found